FOLFIRI (standard of care): Clinical Trials

1 trial of FOLFIRI (standard of care), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow FOLFIRI (standard of care): new trials by email Literature Review of FOLFIRI (standard of care) trials Research Report on FOLFIRI (standard of care)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)
FOLFIRI + Zimberelimab + Domvanalimab, FOLFIRI (standard of care) - Carcinoma, Neuroendocrine
Phase 2Not yet recruitingHospices Civils de Lyon1222026-04-012026-01-13

Conditions studied

Carcinoma, Neuroendocrine (1)

Sponsors

Hospices Civils de Lyon (1)

Countries

France (1)